https://market-scope.com/breaking-po...of-75-percent/
I guess this means at least another year to wait before those of us in Europe can get Xiidra..
Shire also announced that it withdrew Xiidra’s marketing application in Europe from the decentralized procedure. The company plans to resubmit the application through the centralized procedure in Q4-2018.
Comment